The Government has published the level of payment due from members of the Pharmaceutical Price Regulation Scheme (PPRS) in 2017 to keep health service spend on branded medicines within the levels agreed under the Scheme.
The UK pharmaceutical industry trade body, the Association of the British Pharmaceutical Industry (ABPI), have responded to the Prime Minister's speech on the Government's negotiating objectives for exiting the EU.
Read ABPI Chief Executive Stephen Whitehead's speech at the PharmaTimes debate with Ben Goldacre where the final vote on the motion 'Pharma is not getting its act together' swung in favour of industry.
Thank you, Stephen and Simon, for those very kind words. Ladies and gentlemen, it's unusual for a new President to say a lot at their first dinner. Traditionally we accept the chain and allow the outgoing President their last farewell speech.
Ladies and gentlemen ... It falls to me to thank you all for coming to our event today.
Stephen Whitehead, Chief Executive of the ABPI, took part in an interview on BBC Radio 4’s Today programme on the subject of clinical trial data.
The creation of the NICE Implementation Collaborative (NIC) harnesses the skills, experience and dedication of organisations and individuals from across the healthcare system to improve patient outcomes for all.
The ABPI is hosting a workshop to facilitate discussions on how best to address the issue of historical data and disclosure requirements on Thursday 21 March.
The Department of Health has today [27 October] published the Q2 2017 PPRS data showing that the pharmaceutical industry has paid a total of £190 million during the first two quarters of 2017 under the 2014 Pharmaceutical Price Regulation Scheme (PPRS).
Following today’s High Court ruling by Mr Justice Green on the commissioning of Pre-Exposure Prophylaxis (PrEP) and the subsequent appeal of this ruling by NHS England, the Association of the British Pharmaceutical Industry (ABPI) has responded calling for a commissioning process that is fair,...
The Association of the British Pharmaceuticals Industry (ABPI) has welcomed today’s speech from Philip Hammond at Conservative Party Conference, as the Chancellor made two pledges to back the strength and growth of the UK pharmaceuticals sector.